APP and Alzheimer disease: Our lead GGT-resistant GSH-analogue, ψ-GSH, protects cells from Aβ toxicity and reduces AD-related pathology (Aβ deposition, cognitive deficits, and oxidative stress) in the APP/PS1 mouse model of AD [16,17].